Valiant Laboratories Limited (VALIANTLAB.NS)

INR 128.1

(14.76%)

Net Income Summary of Valiant Laboratories Limited

  • Valiant Laboratories Limited's latest annual net income in 2023 was 3.19 Million INR , down -98.9% from previous year.
  • Valiant Laboratories Limited's latest quarterly net income in 2024 Q1 was -5.09 Million INR , up 58.9% from previous quarter.
  • Valiant Laboratories Limited reported an annual net income of 289.98 Million INR in 2022, up 5.46% from previous year.
  • Valiant Laboratories Limited reported an annual net income of 274.96 Million INR in 2021, down -10.12% from previous year.
  • Valiant Laboratories Limited reported a quarterly net income of 7.93 Million INR for 2023 Q2, down -81.41% from previous quarter.
  • Valiant Laboratories Limited reported a quarterly net income of 3.19 Million INR for 2023 FY, down -98.9% from previous quarter.

Annual Net Income Chart of Valiant Laboratories Limited (2023 - 2020)

Historical Annual Net Income of Valiant Laboratories Limited (2023 - 2020)

Year Net Income Net Income Growth
2023 3.19 Million INR -98.9%
2022 289.98 Million INR 5.46%
2021 274.96 Million INR -10.12%
2020 305.93 Million INR 0.0%

Peer Net Income Comparison of Valiant Laboratories Limited

Name Net Income Net Income Difference
Sigachi Industries Limited 571.8 Million INR 99.441%
Ind-Swift Limited 142.31 Million INR 97.754%
Bajaj HealthCare Limited -837.93 Million INR 100.381%
Sakar Healthcare Limited 116.7 Million INR 97.262%
Aurobindo Pharma Limited 31.72 Billion INR 99.99%
Innova Captab Limited 943.45 Million INR 99.661%
Divi's Laboratories Limited 16 Billion INR 99.98%
AstraZeneca Pharma India Limited 1.61 Billion INR 99.802%
Morepen Laboratories Limited 961.59 Million INR 99.668%
Mankind Pharma Limited 19.12 Billion INR 99.983%
Sequent Scientific Limited -358.69 Million INR 100.891%
Wanbury Limited 559.56 Million INR 99.429%
Laurus Labs Limited 1.6 Billion INR 99.801%
Nectar Lifesciences Limited 49.95 Million INR 93.602%
Glenmark Life Sciences Limited 4.7 Billion INR 99.932%
Alembic Limited 2.68 Billion INR 99.881%
Hikal Limited 696 Million INR 99.541%
Alembic Pharmaceuticals Limited 6.15 Billion INR 99.948%
Neuland Laboratories Limited 3 Billion INR 99.893%
J. B. Chemicals & Pharmaceuticals Limited 5.52 Billion INR 99.942%
Glenmark Pharmaceuticals Limited -15.01 Billion INR 100.021%
IOL Chemicals and Pharmaceuticals Limited 1.34 Billion INR 99.762%
Themis Medicare Limited 435.23 Million INR 99.266%
RPG Life Sciences Limited 876.6 Million INR 99.635%
Zydus Lifesciences Limited 38.59 Billion INR 99.992%
Lupin Limited 19.14 Billion INR 99.983%
Amrutanjan Health Care Limited 449.72 Million INR 99.289%
Wockhardt Limited -4.63 Billion INR 100.069%
Vaishali Pharma Limited 7.18 Million INR 55.543%
Aarti Pharmalabs Limited 2.16 Billion INR 99.853%
Jagsonpal Pharmaceuticals Limited 224.63 Million INR 98.577%
Jubilant Pharmova Limited 771 Million INR 99.585%
FDC Limited 3.05 Billion INR 99.895%
Dr. Reddy's Laboratories Limited 55.68 Billion INR 99.994%
Kilitch Drugs (India) Limited 146.01 Million INR 97.811%
Eris Lifesciences Limited 3.91 Billion INR 99.918%
Venus Remedies Limited 284.9 Million INR 98.878%
ZIM Laboratories Limited 172.46 Million INR 98.147%
Bliss GVS Pharma Limited 754.54 Million INR 99.576%
Par Drugs and Chemicals Limited 145.01 Million INR 97.796%
Caplin Point Laboratories Limited 4.57 Billion INR 99.93%
Shilpa Medicare Limited 318.74 Million INR 98.997%
Albert David Limited 754.2 Million INR 99.576%
Ajanta Pharma Limited 8.16 Billion INR 99.961%
Hester Biosciences Limited 188.89 Million INR 98.308%
Suven Pharmaceuticals Limited 3 Billion INR 99.894%
Solara Active Pharma Sciences Limited -5.67 Billion INR 100.056%
Gufic Biosciences Limited 861.35 Million INR 99.629%
Windlas Biotech Limited 581.87 Million INR 99.451%
Procter & Gamble Health Limited 2 Billion INR 99.841%
Aarey Drugs & Pharmaceuticals Limited 46.83 Million INR 93.176%
Mangalam Drugs & Organics Limited -90.71 Million INR 103.523%
Granules India Limited 4.05 Billion INR 99.921%
Aarti Drugs Limited 1.71 Billion INR 99.814%
Bal Pharma Limited 73.92 Million INR 95.677%
Alkem Laboratories Limited 17.95 Billion INR 99.982%
Sun Pharmaceutical Industries Limited 95.76 Billion INR 99.997%
Lincoln Pharmaceuticals Limited 933.04 Million INR 99.657%
Medicamen Biotech Limited 109.31 Million INR 97.076%
Unichem Laboratories Limited -704.74 Million INR 100.453%
Bafna Pharmaceuticals Limited 73.47 Million INR 95.65%
Biofil Chemicals and Pharmaceuticals Limited 7.09 Million INR 54.935%
Orchid Pharma Limited 921.66 Million INR 99.653%
Medico Remedies Limited 82.9 Million INR 96.145%
Ind-Swift Laboratories Limited 4.2 Billion INR 99.924%
Ipca Laboratories Limited 5.47 Billion INR 99.942%
Brooks Laboratories Limited -195.91 Million INR 101.631%
Syncom Formulations (India) Limited 253.14 Million INR 98.737%
Piramal Enterprises Limited -16.83 Billion INR 100.019%
Torrent Pharmaceuticals Limited 16.56 Billion INR 99.981%
NATCO Pharma Limited 13.88 Billion INR 99.977%
Suven Life Sciences Limited -1.05 Billion INR 100.304%
Krebs Biochemicals & Industries Limited -197.28 Million INR 101.62%
Strides Pharma Science Limited -706.14 Million INR 100.453%
Indoco Remedies Limited 984.6 Million INR 99.675%
Alpa Laboratories Limited 167.76 Million INR 98.095%
Lasa Supergenerics Limited -217.3 Million INR 101.471%
Sun Pharma Advanced Research Company Limited -3.87 Billion INR 100.083%